$171.00 Original price was: $171.00.$6.00Current price is: $6.00.
Edited by Paul B Fisher and Carlo Croce, with contributions from renowned experts in the field, this latest volume in the Advances in Cancer Research series delves into the rapidly evolving landscape of cancer research, focusing on the intricate relationship between oncology and gene expression.
This chapter explores the role of non-coding RNAs as potential biomarkers for cancer diagnosis and treatment monitoring. It discusses the various types of non-coding RNAs, their functions, and the challenges and opportunities in utilizing them as biomarkers.
This section delves into the complex and often paradoxical role of microRNAs in cancer. It examines how microRNAs can act as both oncogenes and tumor suppressors, and the implications of these findings for cancer therapy.
This chapter reviews the use of animal models in understanding microRNA functions and their role in cancer. It highlights the strengths and limitations of different model systems and discusses the translational potential of findings from these models.
This comprehensive review covers the diverse roles of non-coding RNAs in cancer, including their involvement in tumorigenesis, metastasis, and drug resistance. It also discusses the therapeutic potential of targeting non-coding RNAs in cancer treatment.
This section focuses on the genetic and epigenetic mechanisms underlying cancer susceptibility, with a particular emphasis on the contribution of microRNAs to these processes. It explores the potential of microRNAs as predictive biomarkers for cancer risk.
This chapter compares and contrasts the functions and regulation of transfer RNA-derived small RNAs (ts-RNAs) and microRNAs in cancer. It highlights the distinct roles of these two classes of small RNAs and their implications for cancer biology and therapy.
This review discusses the specific roles of microRNAs in acute myeloid leukemia (AML), including their involvement in leukemogenesis, disease progression, and treatment response. It also explores the potential of microRNAs as therapeutic targets in AML.
This final chapter examines the interplay between microRNAs and epigenetic mechanisms in cancer. It discusses how microRNAs can influence epigenetic processes and how epigenetic modifications can, in turn, regulate microRNA expression and function.
Author |
---|
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline